DUBLIN--(BUSINESS WIRE)--The "Global Allergy Immunotherapy Market (2017-2021 Edition)" report has been added to Research and Markets' offering.
Global Allergy Immunotherapy Market (2017-2021 Edition), provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc.
The report provides a regional analysis of the allergy immunotherapy market, including the following regions: the US, Europe and Rest of the World.
Growth of the overall global allergy immunotherapy market has also been forecasted for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The key players of the allergy immunotherapy market ALK-Abello, Allergy Therapeutics, Merck Group and Stallergenes, who are also profiled with their financial information and respective business strategies.
The global allergy immunotherapy market has increased at a significant CAGR during the years 2012-2016 and projections are made that the market would rise in the next four years i.e. 2017-2021 tremendously. The allergy immunotherapy market is expected to increase due to growth in healthcare expenditure, rising incidence of chronic diseases and increasing global pollution, etc. Yet the market faces some challenges such as, lack of treatment awareness, lack of investor confidence, anaphylaxia, huge treatment costs, etc.
Key Topics Covered:
1. Executive Summary
3. Global Market Analysis
4. Regional Market Analysis
5. Competitive Landscape
6. Company Profiles
- Allergy Therapeutics
- Merck Group
For more information about this report visit https://www.researchandmarkets.com/research/s22bxc/global_allergy